Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,53 USD | +0,66% | +11,68% | +73,86% |
Vakgebied
Aantal werknemers: 12
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 01-12-08 |
Steven Quay
CEO | Chief Executive Officer | 73 | 01-12-08 |
Heather Rees
DFI | Director of Finance/CFO | - | 01-01-17 |
Arezoo Mirad
CTO | Chief Tech/Sci/R&D Officer | - | 04/12 |
Richard Graydon
CTO | Chief Tech/Sci/R&D Officer | - | 25-10-22 |
Delly Behen
ADM | Chief Administrative Officer | - | 01-01-14 |
Eric van Zanten
IRC | Investor Relations Contact | - | 07-12-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 01-12-08 |
Director/Board Member | 66 | 01-03-14 | |
H. Remmel
BRD | Director/Board Member | 72 | 01-02-12 |
Shu-Chih Chen
FOU | Founder | 62 | 01-12-08 |
Stephen Galli
BRD | Director/Board Member | 77 | 01-07-11 |
Jonathan Finn
BRD | Director/Board Member | 50 | 08/11 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 126 624 110 | 125 230 652 ( 98,90 %) | 1 320 046 ( 1,042 %) | 98,90 % |
Aandeel B | 0 | 582 | 0 | 0 |
Bedrijfsgegevens
Atossa Therapeutics, Inc.
107 Spring Street
98104, Seattle
+206 588 0256
http://www.atossatherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+73,86% | 192 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers ATOS
- Onderneming Atossa Therapeutics, Inc.